Renal Diseases Market Reports Empesis on Targeting Immune and Hormone Signaling Dominating the Pipeline for Chronic Kidney Disease

The Frontier Pharma: Renal Diseases High Degree of Innovation and Diversity with Products Targeting Immune and Hormone Signaling Dominating the Pipeline for Chronic Kidney Disease assesses first-in-class innovation in the renal diseases pipeline, highlighting key trends and emerging treatment classes.

Pune, India - March 14, 2018 /MarketersMedia/ —

The renal diseases therapy area encompasses a range of diseases of the kidney, such as chronic kidney disease (CKD), acute kidney injury, diabetic nephropathy and focal segmental glomerulosclerosis. Renal diseases are becoming increasingly common due to the increased prevalence of hypertension and diabetes, two major causes of CKD. For most forms of renal diseases, early detection and management may slow down or prevent progression to renal failure and associated complications. However, many renal diseases are typically asymptomatic until they have progressed to end-stage renal disease (ESRD), which requires renal replacement therapies such as hemodialysis and renal transplantation, and is associated with substantial morbidity and mortality.

Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-renal-diseases-high-degree-of-innovation-and-diversity-with-products-targeting-immune-and-hormone-signaling-dominating-the-pipeline-for-chronic-kidney-disease

The first-in-class programs identified show considerable diversity, and the relatively high degree of innovation in the renal diseases therapy area makes for a promising development pipeline. It is clear that recent activity in this area has increased, partly owing to the growing recognition of the unmet medical need. Further investment in innovation would benefit the therapy area greatly, and likely prove a worthwhile investment, particularly for highly prevalent diseases such as CKD and diabetic nephropathy, for which there are a lack of effective pharmacotherapeutic options.

Get this report at: https://www.themarketreports.com/report/buy-now/935551

Scope
• With 365 products in active development, the pipeline is modestly sized. Does current pipeline innovation hold the potential to affect the future renal diseases market?
• There are 100 first-in-class products in the renal diseases pipeline. Which of these hold the greatest potential to improve future disease treatment with regard to their molecular target?
• The majority of first-in-class products were in development for indications involving inflammation. Which first-in-class targets are most promising, and how does the ratio of first-in-class targets to first-in-class products differ by stage of development and molecular target class?
• A significant number of first-in-class products have been identified with no prior involvement in deals. How do deal frequency and value compare between target families and molecule types, and which first-in-class programs have not yet been involved in a licensing or co-development deal?

Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/935551

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/renal-diseases-market-reports-empesis-on-targeting-immune-and-hormone-signaling-dominating-the-pipeline-for-chronic-kidney-disease/314328

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-renal-diseases-high-degree-of-innovation-and-diversity-with-products-targeting-immune-and-hormone-signaling-dominating-the-pipeline-for-chronic-kidney-disease%20%20

Source: MarketersMedia

Release ID: 314328

Latest News

China's Xiaomi plans to raise up to $6.1 billion in Hong Kong IPO: sources

Jun 20, 2018

By Fiona Lau and Julie ZhuHONG KONG (Reuters/IFR) - Chinese smartphone maker Xiaomi is planning to raise up to $6.1 billion from a Hong Kong IPO launching this week, people with knowledge of the matter said, in what will be one of the biggest tech floats globally of recent years.Xiaomi, which also makes internet-connected devices, plans to sell about 2.18 billion shares in its initial public offering (IPO) at a price range of HK$17 to HK$22 ($2.17 to $2.80) each, said the people, who declined to be identified as the information was not public.The company plans to bring in eight...

World Cup games to air on free TV amid problems in Australia

Jun 20, 2018

SYDNEY — Rather than risk further outrage from football fans, rights holders in Australia have agreed to keep sharing World Cup matches with free-to-air TV until the end of the group stage. Telecommunications company Optus bought the broadcast rights for most World Cup games in Russia but technical issues with the live streaming in Australia caused a major backlash from subscription buyers — to the point where the prime minister had to intervene. The SBS network, which retained the broadcasting rights for Australia's games and the World Cup final under a sharing agreement with Optus for the 2018 tournament, initially...

ZTE's Hong Kong shares rise after clarification of U.S. bill impact

Jun 20, 2018

By Sijia JiangHONG KONG (Reuters) - Shares of China's ZTE Corp rose as much as 18 percent in Hong Kong on Wednesday as the impact of a U.S. Senate bill that threatens to restore penalties on the company became clearer.In clarification announcements during the noon trading break, ZTE said a National Defense Authorization Act (NDAA) passed by the U.S. Senate on Monday would restore penalties on the company, but the bill would only become law if it could be reconciled with a different version passed by the House of Representatives and signed by U.S. President Trump.That echoed what the White...

Survey: Companies in China feel pressure to give up tech

Jun 20, 2018

BEIJING — One in five foreign companies in China feels compelled to hand over technology for market access, a business group said Wednesday, highlighting a key irritant in an escalating U.S.-Chinese trade dispute. The European Union Chamber of Commerce in China's report follows President Donald Trump's order for tariffs on additional Chinese goods in response to complaints Beijing steals or pressures companies to hand over technology. Out of 532 European companies that responded to a survey, 19 percent "felt compelled to transfer technology in exchange for market access" despite Chinese assurances that it isn't required, the chamber said. "China has...

Australia's Telstra slashes jobs as 'tipping point' forces strategic reset

Jun 20, 2018

By Tom WestbrookSYDNEY (Reuters) - Australia's largest telecom firm Telstra Corp Ltd said it would cut a quarter of its workforce and flagged asset sales on Wednesday, as competition and new technology crush its mainstay fixed-line businesses and force a strategic reset.It will shed 8,000 employees and contractors from a workforce of 32,000 to save A$1 billion ($738 million), drop underperforming products and separate assets it values at A$11 billion from the rest of the firm.It also flagged a fall in 2019 earnings to between A$8.7 billion and A$9.4 billion, excluding restructuring costs of about A$600 million, having already warned...

Sign up now!